Search Results 151-160 of 13421 for Relaxin-2
... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...
About this study. The purpose of this research is to better understand SARS-CoV-2 transmission, and to determine if laboratory tests can predict which ...
July 2, 2025. Mayo Clinic researcher harnesses uniqueness of space to advance medicine on Earth featured image. International. Mayo Clinic researcher harnesses ...
... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...
Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...
... 2 hours, or HbA1c ≥ 6.5%), or IGT (plasma glucose ≥ 140 mg/dL and < 200 mg/dL on a 2-hour oGTT) (American Diabetes Association 2018);; Systolic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.